ctrl K

Watchlist Price Alert

Artiva Biotherapeutics Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

2.08

-0.10 (-4.59%)

At close: May 09, 2025, 3:59 PM

2.06

-0.96%

After-hours: May 09, 2025, 04:52 PM EDT

Artiva Biotherapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	251K	2.6M	29.26M	29.26M	30M	27.64M	989K	989K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	251K	2.6M	29.26M	29.26M	30M	27.64M	989K	989K
Operating Income	-67.28M	-60.99M	-31.84M	-27.48M	-30.67M	-18.7M	-29.51M	-17.69M
Interest Income	4.67M	3.08M	1.65M	1.65M	2.02M	1.44M	1.02M	1.02M
Pretax Income	-55.19M	-56.87M	-28.12M	-29.45M	-32.2M	-21.3M	-32.58M	-16.72M
Net Income	-55.19M	-56.95M	-28.2M	-29.52M	-32.27M	-21.3M	-32.58M	-16.72M
Selling & General & Admin	17.2M	15.42M	13.39M	13.59M	13.91M	10.74M	7.96M	3.91M
Research & Development	50.33M	48.17M	47.71M	46.64M	50.25M	39.1M	26.03M	14.77M
Other Expenses	147K	147K	147K	116K	-84K	-84K	-84K	-53K
Operating Expenses	67.53M	63.59M	61.1M	60.23M	64.16M	49.84M	34M	18.68M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	67.53M	63.59M	61.1M	60.23M	64.16M	49.84M	34M	18.68M
Income Tax Expense	-382K	-310K	-310K	199K	-443K	-515K	-515K	-1.02M
Shares Outstanding (Basic)	11.26M	18.9M	23.28M	17.58M	n/a	9.36M	17.58M	17.58M
Shares Outstanding (Diluted)	11.26M	18.9M	23.28M	17.58M	n/a	9.36M	17.58M	17.58M
EPS (Basic)	-3.15	-2.33	-0.21	-0.49	-0.65	-0.65	-1.85	-0.95
EPS (Diluted)	-3.15	-2.33	-0.21	-0.49	-0.65	-0.65	-1.85	-0.95
EBITDA	-64.85M	-58.58M	-29.5M	-28.7M	-31.9M	-20.53M	-31.89M	-17.11M
EBIT	-67.28M	-60.99M	-31.84M	-30.97M	-34.17M	-22.2M	-33.01M	-17.69M
Depreciation & Amortization	2.43M	2.41M	2.34M	2.27M	2.27M	1.67M	1.12M	578K